Cerebrospinal fluid norepinephrine and cognition in subjects across the adult age span

Neurobiology of Aging

Volumn 34, Issue 10, 2013, Pages 2287-2292

  Wang, Lucy Y ^a,b   Murphy, Richard R ^a,c   Hanscom, Brett ^c   Li, Ge ^a,b   Millard, Steven P ^a   Petrie, Eric C ^a,b   Galasko, Douglas R ^d   Sikkema, Carl ^a   Raskind, Murray A ^a,b   Wilkinson, Charles W ^a,b   Peskind, Elaine R ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Cognition; Noradrenergic system; Norepinephrine

Indexed keywords

NORADRENALIN;

ADULT; AGED; ARTICLE; ATTENTION; CEREBROSPINAL FLUID LEVEL; COGNITION; EDUCATION; ETHNICITY; EXECUTIVE FUNCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROPSYCHOLOGICAL TEST; NORADRENERGIC SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; PROCESSING SPEED; STROOP WORD COLOR INTERFERENCE TASK; TASK PERFORMANCE;

AGING; COGNITION; NORADRENERGIC SYSTEM; NOREPINEPHRINE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ATTENTION; COGNITION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; REPRESSION, PSYCHOLOGY; YOUNG ADULT;

EID: 84879883159     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.04.007     Document Type: Article

References (48)

1. Alexander J.K., Hillier A., Smith R.M., Tivarus M.E., Beversdorf D.Q. Beta-adrenergic modulation of cognitive flexibility during stress. J.Cogn. Neurosci. 2007, 19:468-478.
2. Armitage S. An analysis of certain psychological tests used in the evaluation of brain injury. Psychol. Monogr. 1946, 60:1-48.
3. Arnsten A.F. Stress signalling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci. 2009, 10:410-422.
4. Arnsten A.F. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol. Psychiatry 2011, 69:e89-e99.
5. Bemelmans K.J., Goekoop J.G., de Rijk R., van Kempen G.M. Recall performance, plasma cortisol and plasma norepinephrine in normal human subjects. Biol. Psychol. 2003, 62:1-15.
6. Bolla K.I., Lindgren K.N., Bonaccorsy C., Bleecker M.L. Predictors of verbal fluency (FAS) in the healthy elderly. J.Clin. Psychol. 1990, 46:623-628.
7. Bowman R.E., Ferguson D., Luine V.N. Effects of chronic restraint stress and estradiol on open field activity, spatial memory, and monoaminergic neurotransmitters in ovariectomized rats. Neuroscience 2002, 113:401-410.
8. Campbell H.L., Tivarus M.E., Hillier A., Beversdorf D.Q. Increased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility. Pharmacol. Biochem. Behav. 2008, 88:222-229.
9. Coull J.T., Buchel C., Friston K.J., Frith C.D. Noradrenergically mediated plasticity in a human attentional neuronal network. Neuroimage 1999, 10:705-715.
10. Elrod R., Peskind E.R., DiGiacomo L., Brodkin K.I., Veith R.C., Raskind M.A. Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration. Am. J. Psychiatry 1997, 154:25-30.
11. Esler M., Hastings J., Lambert G., Kaye D., Jennings G., Seals D.R. The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R909-R916.
12. Faigel H.C. The effect of beta blockade on stress-induced cognitive dysfunction in adolescents. Clin. Pediatr. (Phila) 1991, 30:441-445.
13. Featherstone J.A., Veith R.C., Flatness D., Murburg M.M., Villacres E.C., Halter J.B. Age and alpha-2 adrenergic regulation of plasma norepinephrine kinetics in humans. J.Gerontol. 1987, 42:271-276.
14. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
15. Haller J., Makara G.B., Kruk M.R. Catecholaminergic involvement in the control of aggression: hormones, the peripheral sympathetic, and central noradrenergic systems. Neurosci. Biobehav. Rev. 1997, 22:85-97.
16. Hartikainen P., Soininen H., Reinikainen K.J., Sirvio J., Soikkeli R., Riekkinen P.J. Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors. J.Neural. Transm. Gen. Sect. 1991, 84:103-117.
17. Hermans E.J., van Marle H.J.F., Ossewaarde L., Henckens M.J.A.G., Qin S., van Kesteren M.T.R., Schoots V.C., Cousijn H., Rijpkema M., Oostenveld R., Fernández G. Stress-related noradrenergic activity prompts large-scale neural network reconfiguration. Science 2011, 334:1151-1153.
18. Hoeldtke R.D., Cilmi K.M. Effects of aging on catecholamine metabolism. J.Clin. Endocrinol. Metab. 1985, 60:479-484.
19. Holmes C., Eisenhofer G., Goldstein D.S. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J.Chromatogr. B Biomed. Appl. 1994, 653:131-138.
20. Klinkenberg I., Sambeth A., Blokland A. Acetylcholine and attention. Behav. Brain Res. 2011, 221:430-442.
21. Lawlor B.A., Bierer L.M., Ryan T.M., Schmeidler J., Knott P.J., Williams L.L., Mohs R.C., Davis K.L. Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease. Biol. Psychiatry 1995, 38:185-188.
22. Li G., Peskind E.R., Millard S.P., Chi P., Sokal I., Yu C.E., Bekris L.M., Raskind M.A., Galasko D.R., Montine T.J. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One 2009, 4:e5424.
23. Luine V.N., Beck K.D., Bowman R.E., Frankfurt M., Maclusky N.J. Chronic stress and neural function: accounting for sex and age. J.Neuroendocrinol. 2007, 19:743-751.
24. McGaugh J.L., Roozendaal B. Drug enhancement of memory consolidation: historical perspective and neurobiological implications. Psychopharmacology (Berl) 2009, 202:3-14.
25. Morris J.C. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr. 1997, 9(suppl 1):173-176. discussion 7-8.
26. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165.
27. Peskind E.R., Li G., Shofer J., Quinn J.F., Kaye J.A., Clark C.M., Farlow M.R., DeCarli C., Raskind M.A., Schellenberg G.D., Lee V.M.Y., Galasko D.R. Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch. Neurol. 2006, 63:936-939.
28. Peskind E.R., Wilkinson C.W., Petrie E.C., Schellenberg G.D., Raskind M.A. Increased CSF cortisol in AD is a function of APOE genotype. Neurology 2001, 56:1094-1098.
29. Ramos B.P., Arnsten A.F. Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol. Ther. 2007, 113:523-536.
30. Raskind M.A., Peskind E.R., Holmes C., Goldstein D.S. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol. Psychiatry 1999, 46:756-765.
31. Raskind M.A., Peskind E.R., Veith R.C., Beard J.C., Gumbrecht G., Halter J.B. Increased plasma and cerebrospinal fluid norepinephrine in older men: differential suppression by clonidine. J.Clin. Endocrinol. Metab. 1988, 66:438-443.
32. Reus V.I., Silberman E., Post R.M., Weingartner H. d-Amphetamine: effects on memory in a depressed population. Biol. Psychiatry 1979, 14:345-356.
33. Robbins T.W., Arnsten A.F. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu. Rev. Neurosci. 2009, 32:267-287.
34. Rogers S.L., Farlow M.R., Doody R.S., Mohs R., Friedhoff L.T. A24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 1998, 50:136-145.
35. Rowe J.W., Troen B.R. Sympathetic nervous system and aging in man. Endocr. Rev. 1980, 1:167-179.
36. Sara S.J. The locus coeruleus and noradrenergic modulation of cognition. Nat. Rev. Neurosci. 2009, 10:211-223.
37. Stormer V.S., Passow S., Biesenack J., Li S.C. Dopaminergic and cholinergic modulations of visual-spatial attention and working memory: insights from molecular genetic research and implications for adult cognitive development. Dev. Psychol. 2012, 48:875-889.
38. Stroop J. Studies of interference in serial verbal reactions. J.Exp. Psychol. 1935, 18:643-662.
39. Supiano M.A., Linares O.A., Smith M.J., Halter J.B. Age-related differences in norepinephrine kinetics: effect of posture and sodium-restricted diet. Am. J.Physiol. 1990, 259(Pt 1):E422-E431.
40. Szot P., Knight L., Franklin A., Sikkema C., Foster S., Wilkinson C.W., White S.S., Raskind M.A. Lesioning noradrenergic neurons of the locus coeruleus in C57Bl/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling. Neuroscience 2012, 216:143-157.
41. Van Ruitenbeek P., Vermeeren A., Riedel W.J. Cognitive domains affected by histamine H(1)-antagonism in humans: a literature review. Brain Res. Rev. 2010, 64:263-282.
42. Veith R.C., Featherstone J.A., Linares O.A., Halter J.B. Age differences in plasma norepinephrine kinetics in humans. J.Gerontol. 1986, 41:319-324.
43. Wallace T.L., Ballard T.M., Pouzet B., Riedel W.J., Wettstein J.G. Drug targets for cognitive enhancement in neuropsychiatric disorders. Pharmacol. Biochem. Behav. 2011, 99:130-145.
44. Wechsler D., Stone C. Manual: Wechsler Memory Scale 1973, Psychological Corporation, New York.
45. Weintraub S., Salmon D., Mercaldo N., Ferris S., Graff-Radford N.R., Chui H., Cummings J., DeCarli C., Foster N.L., Galasko D., Peskind E., Dietrich W., Beekly D.L., Kukull W.A., Morris J.C. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis. Assoc. Disord. 2009, 23:91-101.
46. Wilkosc M., Hauser J., Tomaszewska M., Dmitrzak-Weglarz M., Skibinska M., Szczepankiewicz A., Borkowska A. Influence of dopaminergic and serotoninergic genes on working memory in healthy subjects. Acta Neurobiol. Exp. 2010, 70:86-94.
47. Wolf O.T., Schommer N.C., Hellhammer D.H., McEwen B.S., Kirschbaum C. The relationship between stress induced cortisol levels and memory differs between men and women. Psychoneuroendocrinology 2001, 26:711-720.
48. Wolkowitz O.M., Weingartner H., Rubinow D.R., Jimerson D., Kling M., Berretini W., Thompson K., Breier A., Doran A., Reus V.I. Steroid modulation of human memory: biochemical correlates. Biol Psychiatry 1993, 33:744-746.